Coral Laboratories Ltd — Board Meeting, 13-08-2025: Board Meeting

Coral Laboratories has announced a board meeting, where it approved the financial results for the quarter ended June 30, 2025. Revenue from operations was ₹18.82 Cr, with total income at ₹20.87 Cr, and profit for the period at ₹2.56 Cr (EPS ₹7.18). The company will convene its 43rd Annual General Meeting on September 26, 2025. The board also approved the appointment of M/s. S C Mehra & Associates LLP as new statutory auditors for five years, succeeding the previous auditor, subject to shareholder approval. Furthermore, the company will expand its business scope by altering its Memorandum of Association, adding broader pharmaceutical and healthcare product activities, also pending shareholder approval.